Impact of Transgender Healthcare Practices on Children
Dr. Hillary Cass, author of a report on transgender healthcare for children, is facing abuse and threats, including being advised to avoid public transport due to security concerns. The report challenges the use of puberty-blocking drugs for children, stating there is little evidence to support their efficacy and warning of potential risks. The UK's National Health Service has stopped routinely providing puberty blockers to children in most cases, but concerns remain about loopholes that could allow activist physicians to continue prescribing them.
Key Points
- Little evidence to support efficacy of puberty-blocking drugs for children
- Long-term effects of treatment not thoroughly explored
- Many children naturally grow out of experiencing a transgender identity
Cons
- Dr. Cass is facing abuse and threats for her report
- Challenges the use of puberty-blocking drugs for children
- Concerns about loopholes allowing continued prescription of life-altering medications